Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News

August 30, 2013
Diabetes Raises the Risk of Disability Among Seniors
Seniors with diabetes have a greater than 50 percent increased risk of developing a physical disability that hampers their ability to conduct daily activities.
August 29, 2013
Insufficient Evidence to Support Universal HIV Treatment?
A group of HIV experts believes there is not yet enough evidence to support universal antiretroviral treatment regardless of CD4 levels.
First Kidney Transplant Between People With HIV Is a Success
Israeli physicians have successfully conducted the world’s first kidney transplant between two living people who have HIV.
August 27, 2013
HIV May Super Charge Cocaine’s Effects and Promote Relapse
Thanks to a protein integral to HIV’s life cycle, cocaine may have a greater effect on people with HIV and make them more susceptible to relapse.
August 26, 2013
Treat Hep C if HIV-Coinfected Have Advanced Fibrosis
Those coinfected with hepatitis C and HIV who have advanced fibrosis should receive hep C therapy, because of the risk of developing liver decompensation.
Heart Rhythm Risks Among Methadone Users With HIV
People with HIV who are on methadone maintenance therapy have an elevated risk of hearth rhythm abnormalities that can prove fatal.
August 23, 2013
Missing Appointments Post-HIV Diagnosis Raises Risk of Death
Those who miss one or more medical appointments during the first year after being diagnosed with HIV have a much higher risk of death.
August 22, 2013
U.S. Revises Guidelines for Occupational HIV Exposure
The U.S. Public Health Service has revised its guidelines for occupational exposure to HIV, advising three HIV drugs for four weeks instead of two or three.
August 21, 2013
CD4s at Entry Into HIV Care Largely Unchanged in 20 Years
For people with HIV living in resource-rich nations, the average CD4 count upon entry into care has not seen an appreciable increase during the past two decades.
August 20, 2013
Preventive Therapy Lowers TB Deaths in People With HIV
Isoniazid preventive therapy (IPT) for tuberculosis greatly reduces the risk that people with HIV will develop TB or die of the disease.
August 19, 2013
Exercise Improves Brain Function in People With HIV
Physically active HIV-positive people are much more likely to have improved brain function over those who lead sedentary lives.
August 16, 2013
Strong Support for Vaccinating Young Gay Men for HPV
Numerous studies have suggested that the vaccine for human papillomavirus (HPV) strongly benefits young gay men.
August 15, 2013
Malaria Vaccine Shows Promise, With Caveats
A new malaria vaccine has shown 100 percent effectiveness at preventing the infection in a small trial.
Vaccinations for Meningitis Appear to Protect NYC Gays
Widespread vaccinations against meningitis among New York City gay men appears to have succeeded in significantly hampering the recent outbreak.
August 13, 2013
FDA Approves HIV Drug Tivicay (Dolutegravir)
The FDA has approved ViiV Healthcare’s HIV med Tivicay (dolutegravir), the second approved antiretroviral (ARV) in the integrase strand transfer class.
August 12, 2013
FDA OKs First Rapid Test That Can Detect Acute HIV
The FDA has approved the first rapid HIV test that can detect both HIV-1 and HIV-2 antibodies as well as a key antigen indicating a recent infection with HIV-1. 
No Link Between Pot and Liver Disease in HIV/Hep C Coinfected
There is no apparent association between the use of marijuana and the progression of liver fibrosis in those coinfected with hepatitis C virus (HCV) and HIV.
August 09, 2013
Monkeys Achieve Drug-Free Control of SIV
Adding an arthritis drug and a chemotherapy drug to a highly intensified HIV drug regimen appears to have led to a drug-free control of SIV among monkeys.
August 08, 2013
Low CD4s and Cardiovascular Disease Only Weakly Linked
A suppressed immune system among people with HIV has only a tenuous connection to an increased risk of heart attack and coronary heart disease.
August 07, 2013
Booze Doesn’t Affect Treatment Failure or CD4 Count
A new study argues that consumption of alcohol appears unrelated to CD4 levels or treatment failure rates.
August 06, 2013
Compound in Soybeans May Fight HIV
Early research into a compound found in soybeans suggests that it may be used to fight HIV and that it would be less susceptible to drug resistance.
August 05, 2013
FDA OKs Generic Truvada for Use Abroad
The U.S. Food and Drug Administration (FDA) has approved a generic version of Gilead Sciences’ HIV antiretroviral Truvada for use outside the U.S.
Liver Cancer Deaths Double in Two Decades
The rates of liver cancer in the United States more than doubled between 1990 and 2010 while deaths resulting from cirrhosis jumped 43 percent.
August 02, 2013
A Call to Count More HPV Cancers as AIDS-Defining Illnesses
A Connecticut health groups has called for the CDC to expand the definition of “AIDS-defining illnesses” to include the full range of HPV–related cancers.
August 01, 2013
New HIV Diagnoses Spike Alarmingly Among London Gays
The number of new HIV diagnoses among gay men in London is rising rapidly, possibly due in part to expanded testing but also because of drug use.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.